comparemela.com

Pharmaceutical News News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Taro to merge with Sun Pharma in $350 million deal

BridgeBio Climbs 4% On Strategic Investment From Blue Owl, CPP Investments

Stock of BridgeBio Pharma, Inc. (BBIO) gained 4 percent on Thursday after the company announced that it will receive strategic financing of up to $1.25 billion from Blue Owl Capital and Canada Pension Plan Investment Board, a subsidiary of CPPIB Credit Investments Inc.

vimarsana © 2020. All Rights Reserved.